These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 27073579)
1. Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor. Tu DG; Yu Y; Lee CH; Kuo YL; Lu YC; Tu CW; Chang WW Oncol Lett; 2016 Apr; 11(4):2934-2940. PubMed ID: 27073579 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cells. Lee CH; Wu YT; Hsieh HC; Yu Y; Yu AL; Chang WW Biochimie; 2014 Sep; 104():117-26. PubMed ID: 24950183 [TBL] [Abstract][Full Text] [Related]
3. Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells. Chen SM; Wang BY; Lee CH; Lee HT; Li JJ; Hong GC; Hung YC; Chien PJ; Chang CY; Hsu LS; Chang WW Oncotarget; 2017 Sep; 8(44):76057-76068. PubMed ID: 29100291 [TBL] [Abstract][Full Text] [Related]
4. Function of AURKA protein kinase in the formation of vasculogenic mimicry in triple-negative breast cancer stem cells. Liu Y; Sun B; Liu T; Zhao X; Wang X; Li Y; Meng J; Gu Q; Liu F; Dong X; Liu P; Sun R; Zhao N Onco Targets Ther; 2016; 9():3473-84. PubMed ID: 27366084 [TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of compound DMBT on hypoxia-induced vasculogenic mimicry in human breast cancer. Li S; Zhang Q; Zhou L; Guan Y; Chen S; Zhang Y; Han X Biomed Pharmacother; 2017 Dec; 96():982-992. PubMed ID: 29208325 [TBL] [Abstract][Full Text] [Related]
6. Hinokitiol suppresses growth of B16 melanoma by activating ERK/MKP3/proteosome pathway to downregulate survivin expression. Wei KC; Chen RF; Chen YF; Lin CH Toxicol Appl Pharmacol; 2019 Mar; 366():35-45. PubMed ID: 30684529 [TBL] [Abstract][Full Text] [Related]
7. Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway. Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715 [TBL] [Abstract][Full Text] [Related]
8. Hinokitiol, a tropolone derivative, inhibits mouse melanoma (B16-F10) cell migration and in vivo tumor formation. Huang CH; Lu SH; Chang CC; Thomas PA; Jayakumar T; Sheu JR Eur J Pharmacol; 2015 Jan; 746():148-57. PubMed ID: 25449038 [TBL] [Abstract][Full Text] [Related]
9. Hinokitiol inhibits compound action potentials in the frog sciatic nerve. Magori N; Fujita T; Kumamoto E Eur J Pharmacol; 2018 Jan; 819():254-260. PubMed ID: 29225186 [TBL] [Abstract][Full Text] [Related]
10. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines. Liu S; Yamauchi H Biochem Biophys Res Commun; 2006 Dec; 351(1):26-32. PubMed ID: 17055455 [TBL] [Abstract][Full Text] [Related]
11. Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer. Wahler J; So JY; Cheng LC; Maehr H; Uskokovic M; Suh N J Steroid Biochem Mol Biol; 2015 Apr; 148():148-55. PubMed ID: 25445919 [TBL] [Abstract][Full Text] [Related]
12. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function. Liu S; Yamauchi H Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells. Aikins AR; Kim M; Raymundo B; Kim CW Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861 [TBL] [Abstract][Full Text] [Related]
14. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation. Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346 [TBL] [Abstract][Full Text] [Related]
15. Propofol Reduced Mammosphere Formation of Breast Cancer Stem Cells via PD-L1/Nanog Zhang X; Li F; Zheng Y; Wang X; Wang K; Yu Y; Zhao H Oxid Med Cell Longev; 2019; 2019():9078209. PubMed ID: 30906504 [TBL] [Abstract][Full Text] [Related]
16. Tumor vasculogenic mimicry formation as an unfavorable prognostic indicator in patients with breast cancer. Shen Y; Quan J; Wang M; Li S; Yang J; Lv M; Chen Z; Zhang L; Zhao X; Yang J Oncotarget; 2017 Aug; 8(34):56408-56416. PubMed ID: 28915600 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional Tandem Peptide Modified Paclitaxel-Loaded Liposomes for the Treatment of Vasculogenic Mimicry and Cancer Stem Cells in Malignant Glioma. Liu Y; Mei L; Yu Q; Xu C; Qiu Y; Yang Y; Shi K; Zhang Q; Gao H; Zhang Z; He Q ACS Appl Mater Interfaces; 2015 Aug; 7(30):16792-801. PubMed ID: 26173814 [TBL] [Abstract][Full Text] [Related]
18. Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity. Giordano C; Chemi F; Panza S; Barone I; Bonofiglio D; Lanzino M; Cordella A; Campana A; Hashim A; Rizza P; Leggio A; Győrffy B; Simões BM; Clarke RB; Weisz A; Catalano S; Andò S Oncotarget; 2016 Jan; 7(2):1262-75. PubMed ID: 26556856 [TBL] [Abstract][Full Text] [Related]
19. Stem-like Human Breast Cancer Cells Initiate Vasculogenic Mimicry on Matrigel. Izawa Y; Kashii-Magaribuchi K; Yoshida K; Nosaka M; Tsuji N; Yamamoto A; Kuroyanagi K; Tono K; Tanihata M; Imanishi M; Onishi M; Sakiyama M; Inoue S; Takahashi R Acta Histochem Cytochem; 2018 Dec; 51(6):173-183. PubMed ID: 30647492 [TBL] [Abstract][Full Text] [Related]
20. Hinokitiol induces autophagy in murine breast and colorectal cancer cells. Wang WK; Lin ST; Chang WW; Liu LW; Li TY; Kuo CY; Hsieh JL; Lee CH Environ Toxicol; 2016 Jan; 31(1):77-84. PubMed ID: 25044443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]